Retinal Vein Occlusion
Showing 76 - 100 of 116
Macular Edema, Retinal Vein Occlusion Trial in Seoul (ranibizumab)
Completed
- Macular Edema
- Retinal Vein Occlusion
-
Seoul, Korea, Republic ofDept. of ophthalmology, Kyung Hee University Medical Center
Sep 27, 2016
Resistance to Antibiotics in Patients Receiving Eye Injections
Completed
- Age-Related Macular Degeneration
- +2 more
- Conjunctival and nasopharyngeal swabs
-
Edison, New JerseyNJ Retina
May 31, 2016
Ranibizumab in Real Life Setting
Completed
- Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
- +3 more
-
Lanus, Buenos Aires, Argentina
- +462 more
May 20, 2016
Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial (Blood Sample Collection, Aflibercept,
Completed
- Age-related Macular Degeneration
- +2 more
- Blood Sample Collection
- +3 more
- (no location specified)
Apr 13, 2016
Retinal Vein Occlusion Trial in Germany (RFB002, Dexamethasone)
A Long-Term Safety Study of OZURDEX® in Clinical Practice
Completed
- Retinal Vein Occlusion
- +2 more
- dexamethasone 700 μg intravitreal implant
-
Paris, France
- +3 more
Apr 18, 2016
Retinal Vein Occlusion Trial in Baltimore (Ranibizumab 0.5mg (monthly), Ranibizumab 2.0mg (monthly), Pro re nata (prn)
Completed
- Retinal Vein Occlusion
- Ranibizumab 0.5mg (monthly)
- +3 more
-
Baltimore, MarylandWilmer Eye Institute at Johns Hopkins University
Feb 16, 2016
Ozurdex® Treatment Practice in Macular Oedema Due to Retinal
Completed
- Macular Edema
- Retinal Vein Occlusion
- dexamethasone intravitreal implant
-
Paris, France(unnamed)
Feb 16, 2016
Dexamethasone (OZURDEX®) Intravitreal Implant in Korea
Completed
- Retinal Vein Occlusion
- dexamethasone 700 ㎍ intravitreal implant
-
Seoul, Korea, Republic of(unnamed)
Dec 8, 2015
Retinal Vein Occlusion Trial in New York City (Ranibizumab (Lucentis ))
Completed
- Retinal Vein Occlusion
- Ranibizumab (Lucentis )
-
New York City, New YorkVitreous Retina Macula Consultants of New York, P.C.
Dec 31, 2015
Retinal Vein Occlusion, Macular Edema Trial (ranibizumab, Squalamine Lactate Ophthalmic Solution, 0.2%)
Completed
- Retinal Vein Occlusion
- Macular Edema
- ranibizumab
- Squalamine Lactate Ophthalmic Solution, 0.2%
- (no location specified)
Nov 24, 2015
Retinal Vein Occlusion Trial in Amsterdam (Bevacizumab, Ranibizumab)
Unknown status
- Retinal Vein Occlusion
-
Amsterdam, NetherlandsAcademic Medical Center, Dept. Ophthalmology
Jun 30, 2015
Macular Edema, Retinal Vein Occlusion Trial in Lexington, Boston, Cleveland (Fluocinolone Acetonide)
Terminated
- Macular Edema
- Retinal Vein Occlusion
- Fluocinolone Acetonide
-
Lexington, Kentucky
- +2 more
May 8, 2015
Patients With Macular Oedema Receiving OZURDEX®
Completed
- Macular Edema
- Retinal Vein Occlusion
- No Intervention
-
Warsaw, Poland(unnamed)
May 21, 2015
Retinal Vein Occlusion Trial in Baltimore (dexamethasone implant)
Completed
- Retinal Vein Occlusion
- dexamethasone implant
-
Baltimore, MarylandWilmer Eye Institute
Apr 2, 2015
Retinal Vein Occlusion Trial in Philadelphia (Dexamethasone intravitreal implant, Monthly Ranibizumab)
Unknown status
- Retinal Vein Occlusion
- Dexamethasone intravitreal implant
- Monthly Ranibizumab
-
Philadelphia, PennsylvaniaWills Eye Retina Service
Feb 19, 2015
OZURDEX® for Branch Retinal Vein Occlusion and Central Retinal
Completed
- Retinal Vein Occlusion
- Macular Edema
- No Intervention
-
Glostrup, Denmark
- +2 more
Jan 27, 2015
Retinal Vein Occlusion Trial in Worldwide (Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321), Sham treatment)
Completed
- Retinal Vein Occlusion
- Aflibercept Injection (EYLEA, VEGF Trap-Eye, BAY86-5321)
- Sham treatment
-
Chatswood, New South Wales, Australia
- +72 more
Oct 27, 2014
Retinal Vein Occlusion Trial in Nashville (Aflibercept)
Unknown status
- Retinal Vein Occlusion
-
Nashville, TennesseeTennessee Retina, PC
Oct 27, 2014
Phase-variance Optical Coherence Tomography and Fluorescein
Terminated
- Age-related Macular Degeneration
- +4 more
- Phase variance optical coherence tomography (PV-OCT)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 3, 2014
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (AGN208397 intravitreal injection, dexamethasone intravitreal implant)
Completed
- Macular Edema
- Retinal Vein Occlusion
- AGN208397 intravitreal injection
- dexamethasone intravitreal implant
-
Phoenix, Arizona
- +4 more
Mar 27, 2014
Retinal Vein Occlusion Trial in Beijing, Wenzhou (Conbercept)
Unknown status
- Retinal Vein Occlusion
- Conbercept
-
Beijing, Beijing, China
- +1 more
Mar 25, 2014
Macular Edema, Retinal Vein Occlusion Trial in Spain (Avastin Intravitreal Injection, Sham Avastin Intravitreal Injection)
Completed
- Macular Edema
- Retinal Vein Occlusion
- Avastin Intravitreal Injection
- Sham Avastin Intravitreal Injection
-
Santiago de Compostela, La Coruña, Spain
- +12 more
Mar 18, 2014
Retinal Vein Occlusion Trial in United States (ranibizumab, Peripheral Laser)
Completed
- Retinal Vein Occlusion
- ranibizumab
- Peripheral Laser
-
Beverly Hills, California
- +5 more
Nov 27, 2013
Macular Edema, Retinal Vein Occlusion Trial in Baltimore (Intravitreal injection of ranibizumab .3 dose, Intravitreal injection
Completed
- Macular Edema
- Retinal Vein Occlusion
- Intravitreal injection of ranibizumab .3 dose
- Intravitreal injection of Ranibizumab .5 dose
-
Baltimore, MarylandWilmer Eye Institute
Oct 7, 2013